Skip to main content

Table 2 Adverse events from patient-controlled intravenous analgesia

From: S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression: a randomized controlled trial

Adverse events

C group (%)

S group (%)

Total (%)

P-value

Headache

5 (3.3)

5 (4.1)

10 (3.6)

0.755

Nausea

9 (5.9)

10 (8.2)

19 (6.9)

0.481

Dizzy

14 (9.2)

15 (12.3)

29 (10.5)

0.434

Drowsiness

10 (6.5)

13 (10.7)

23 (8.4)

0.274

Vomit

9 (5.9)

7 (5.7)

16 (5.8)

0.585